Provided by Tiger Trade Technology Pte. Ltd.

Novel Coronavirus Treatment

948.336
-13.438-1.40%
Number of Gainers:7
Number of Losers:14
Number of Flat:12
PE:- -
High:957.709
Open:953.391
Low:944.044
Close:961.774
Volume:38.50M
Turnover:479.78M
Market Cap:235.77B
Float Cap:191.65B

Loading ...

Csl FY Adjusted Net Income USD 3,100 Million

Reuters
·
Aug 18

Shares of CSL Limited up 12.9% at A$152 in Early Trade After Annual Results

THOMSON REUTERS
·
Aug 18

Australia's CSL Surges 18% on Earnings Beat, Upbeat Plasma Business Forecast

Reuters
·
Aug 18

CSL FY26 Underlying NPATA Falls 2% to Us$3.1 Billion; Reported Net Loss Widens to Us$2.6 Billion

Reuters
·
Aug 18

Lark Distilling FY Ebitda AUD -4.5 Million

THOMSON REUTERS
·
Aug 18

Lark Distilling FY Revenue AUD 18 Million

THOMSON REUTERS
·
Aug 18

CSL Final Dividend Us$1.62 Per Share

THOMSON REUTERS
·
Aug 18

CSL Limited - Announce a Further A$1.1 Billion Share Buy-Back Program

THOMSON REUTERS
·
Aug 18

CSL Limited - Recognised Pre-Tax Impairments of $5.5 Billion in 2H FY26

THOMSON REUTERS
·
Aug 18

CSL Limited Sees FY Underlying Npat Growth of Approximately 5%

THOMSON REUTERS
·
Aug 18

CSL Limited - Intention to Spend Approximately $1.5 Billion to Expand Its U.S. Plasma Manufacturing Presence

THOMSON REUTERS
·
Aug 18

CSL FY Adjusted Net Income USD 3,100 Million

THOMSON REUTERS
·
Aug 18

CSL Limited - CSL Seqirus Expects Low Single Digit Revenue Growth in FY

THOMSON REUTERS
·
Aug 18

ASX Insights Lynas Rare Earths And 2 Stocks That Might Be Priced Below Their Estimated Value

Simply Wall St.
·
Aug 18

3 ASX Dividend Stocks Paying Investors While They Wait

Simply Wall St.
·
Aug 18

Why Retail Investors Are Tracking These 3 Founder Led Australian Stocks Today

Simply Wall St.
·
Aug 17

Dimerix Completes Transfer of Acute Kidney Injury Drug Candidate's US Investigational New Drug Application, Shares Up 6%

MT Newswires Live
·
Aug 17

Mesoblast Completes Dosing in Phase 3 Rexlemestrocel-L Trial for Chronic Low Back Pain

Reuters
·
Aug 17

Mesoblast Achieves Major Milestone Completing Patient Treatment in Pivotal Phase 3 Trial for Chronic Low Back Pain

THOMSON REUTERS
·
Aug 17

Market Chatter: Coles Group, Woolworths Test Facial Recognition Technology to Thwart Crime

MT Newswires Live
·
Aug 17